Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1055

1.

Transition to a new electronic health record and pediatric medication safety: lessons learned in pediatrics within a large academic health system.

Whalen K, Lynch E, Moawad I, John T, Lozowski D, Cummings BM.

J Am Med Inform Assoc. 2018 Apr 23. doi: 10.1093/jamia/ocy034. [Epub ahead of print]

PMID:
29688461
2.

The outcome of severe varicella pneumonia with respiratory failure admitted to the intensive care unit for mechanical ventilation.

John KG, John TJ, Taljaard JJ, Lalla U, Esterhuzien TM, Irusen EM, Koegelenberg CF.

Eur Respir J. 2018 Apr 12. pii: 1800407. doi: 10.1183/13993003.00407-2018. [Epub ahead of print] No abstract available.

PMID:
29650562
3.

Quantitative thresholds enable accurate identification of Clostridium difficile infection by the Luminex xTAG GI pathogen panel.

Leal SM Jr., Popowitch EB, Levinson KJ, John TM, Lehman B, Bueno Rios M, Gilligan PH, Miller MB.

J Clin Microbiol. 2018 Apr 11. pii: JCM.01885-17. doi: 10.1128/JCM.01885-17. [Epub ahead of print]

PMID:
29643194
4.

Differentiating the mimickers of acute pericarditis/myopericarditis.

John TJ, Kyriakakis C.

QJM. 2018 Mar 19. doi: 10.1093/qjmed/hcy059. [Epub ahead of print] No abstract available.

PMID:
29562290
5.

Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency.

Lawless D, Geier CB, Farmer JR, Allen Lango H, Thwaites D, Atschekzei F, Brown M, Buchbinder D, Burns SO, Butte MJ, Csomos K, Deevi SVV, Egner W, Ehl S, Eibl MM, Fadugba O, Foldvari Z, Green DM, Henrickson SE, Holland SM, John T, Klemann C, Kuijpers TW, Moreira F, Piller A, Rayner-Matthews P, Romberg ND, Sargur R, Schmidt RE, Schröder C, Schuetz C, Sharapova SO, Smith KGC, Sogkas G, Speckmann C, Stirrups K, Thrasher AJ, Wolf HM, Notarangelo LD, Anwar R, Boyes J, Ujhazi B; NIHR BioResource–Rare Diseases Consortium, Thaventhiran J, Walter JE, Savic S.

J Allergy Clin Immunol. 2018 Mar 2. pii: S0091-6749(18)30292-6. doi: 10.1016/j.jaci.2018.02.007. [Epub ahead of print] No abstract available.

6.

Numerical-experimental observation of shape bistability of red blood cells flowing in a microchannel.

Guckenberger A, Kihm A, John T, Wagner C, Gekle S.

Soft Matter. 2018 Mar 14;14(11):2032-2043. doi: 10.1039/c7sm02272g.

PMID:
29473072
7.

Atrialized right ventricular myxoma in a patient with Ebstein's anomaly.

John TJ, Snyman HW, Janson J, Pecoraro AJK.

Echo Res Pract. 2018 Feb 21. pii: ERP-17-0065. doi: 10.1530/ERP-17-0065. [Epub ahead of print]

8.

Transient Receptor Potential Channels TRPM4 and TRPC3 Critically Contribute to Respiratory Motor Pattern Formation but not Rhythmogenesis in Rodent Brainstem Circuits.

Koizumi H, John TT, Chia JX, Tariq MF, Phillips RS, Mosher B, Chen Y, Thompson R, Zhang R, Koshiya N, Smith JC.

eNeuro. 2018 Feb 9;5(1). pii: ENEURO.0332-17.2018. doi: 10.1523/ENEURO.0332-17.2018. eCollection 2018 Jan-Feb.

9.

ECG Spot Diagnosis: Acute Pericarditis.

John TJ, John K, Titus G, Kyriakakis C.

QJM. 2018 Feb 8. doi: 10.1093/qjmed/hcy023. [Epub ahead of print] No abstract available.

PMID:
29432566
10.

In Reply to Leone.

Do H, Arulananda S, John T, Dobrovic A.

J Thorac Oncol. 2018 Feb;13(2):e22-e23. doi: 10.1016/j.jtho.2017.11.119. No abstract available.

PMID:
29425615
11.

Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?

John T, Chia PL.

Clin Cancer Res. 2018 Apr 1;24(7):1513-1515. doi: 10.1158/1078-0432.CCR-17-3493. Epub 2018 Jan 19.

PMID:
29351918
12.

The syndrome of acute encephalitis in children in India: Need for new thinking.

John TJ, Verghese VP, Arunkumar G, Gupta N, Swaminathan S.

Indian J Med Res. 2017 Aug;146(2):158-161. doi: 10.4103/ijmr.IJMR_1497_16. No abstract available.

13.

Development and implementation of a screen-and-refer approach to addressing maternal depression, substance use, and intimate partner violence in home visiting clients.

Dauber S, John T, Hogue A, Nugent J, Hernandez G.

Child Youth Serv Rev. 2017 Oct;81:157-167. doi: 10.1016/j.childyouth.2017.07.021. Epub 2017 Jul 25.

PMID:
29249846
14.

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators.

N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18.

PMID:
29151359
15.

Mental Health Screening Quality Improvement Learning Collaborative in Pediatric Primary Care.

Beers LS, Godoy L, John T, Long M, Biel MG, Anthony B, Mlynarski L, Moon R, Weissman M.

Pediatrics. 2017 Dec;140(6). pii: e20162966. doi: 10.1542/peds.2016-2966. Epub 2017 Nov 7.

PMID:
29114061
16.

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer.

Chüeh AC, Liew MS, Russell PA, Walkiewicz M, Jayachandran A, Starmans MHW, Boutros PC, Wright G, Barnett SA, Mariadason JM, John T.

Oncotarget. 2017 May 23;8(43):74036-74048. doi: 10.18632/oncotarget.18198. eCollection 2017 Sep 26.

17.

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.

Ahn MJ, Kim DW, Cho BC, Kim SW, Lee JS, Ahn JS, Kim TM, Lin CC, Kim HR, John T, Kao S, Goldman JW, Su WC, Natale R, Rabbie S, Harrop B, Overend P, Yang Z, Yang JC.

Lancet Respir Med. 2017 Nov;5(11):891-902. doi: 10.1016/S2213-2600(17)30378-8. Epub 2017 Oct 19.

PMID:
29056570
18.

An outbreak of community-acquired pseudomonas aeruginosa pneumonia in a setting of high water stress.

John TJ, Lalla U, Taljaard JJ, John KG, Slabbert J, Koegelenberg CFN.

QJM. 2017 Jul 20. doi: 10.1093/qjmed/hcx148. [Epub ahead of print] No abstract available.

PMID:
29025050
19.

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material.

Cheng YC, Hannaoui S, John TR, Dudas S, Czub S, Gilch S.

J Vis Exp. 2017 Sep 29;(127). doi: 10.3791/56373.

PMID:
28994814
20.

Part-list cuing effects in children: A developmental dissociation between the detrimental and beneficial effect.

John T, Aslan A.

J Exp Child Psychol. 2018 Feb;166:705-712. doi: 10.1016/j.jecp.2017.08.013. Epub 2017 Sep 22.

PMID:
28943058
21.

Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease.

John T, Tighe S, Sheha H, Hamrah P, Salem ZM, Cheng AMS, Wang MX, Rock ND.

J Ophthalmol. 2017;2017:6404918. doi: 10.1155/2017/6404918. Epub 2017 Aug 15.

22.

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

Grosso F, Steele N, Novello S, Nowak AK, Popat S, Greillier L, John T, Leighl NB, Reck M, Taylor P, Planchard D, Sørensen JB, Socinski MA, von Wangenheim U, Loembé AB, Barrueco J, Morsli N, Scagliotti G.

J Clin Oncol. 2017 Nov 1;35(31):3591-3600. doi: 10.1200/JCO.2017.72.9012. Epub 2017 Sep 11.

PMID:
28892431
23.

De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.

Thai A, Chia PL, Russell PA, Do H, Dobrovic A, Mitchell P, John T.

Intern Med J. 2017 Sep;47(9):1071-1074. doi: 10.1111/imj.13531.

PMID:
28891180
24.

How kanamycin A interacts with bacterial and mammalian mimetic membranes.

John T, Thomas T, Abel B, Wood BR, Chalmers DK, Martin LL.

Biochim Biophys Acta. 2017 Nov;1859(11):2242-2252. doi: 10.1016/j.bbamem.2017.08.016. Epub 2017 Aug 26.

PMID:
28847502
25.

Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer.

Arulananda S, Do H, Musafer A, Mitchell P, Dobrovic A, John T.

J Thorac Oncol. 2017 Nov;12(11):1728-1732. doi: 10.1016/j.jtho.2017.08.006. Epub 2017 Aug 24.

PMID:
28843359
26.

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.

Ramalingam SS, Yang JC, Lee CK, Kurata T, Kim DW, John T, Nogami N, Ohe Y, Mann H, Rukazenkov Y, Ghiorghiu S, Stetson D, Markovets A, Barrett JC, Thress KS, Jänne PA.

J Clin Oncol. 2018 Mar 20;36(9):841-849. doi: 10.1200/JCO.2017.74.7576. Epub 2017 Aug 25.

PMID:
28841389
27.

Does access to private healthcare influence potential lung cancer cure rates?

John TJ, Plekker D, Irusen EM, Koegelenberg CFN.

S Afr Med J. 2017 Jul 28;107(8):687-690. doi: 10.7196/SAMJ.2017.v107i8.12277.

28.

Lychee-associated acute hypoglycaemic encephalopathy outbreaks in Muzaffarpur, India.

Das M, John TJ.

Lancet Glob Health. 2017 Sep;5(9):e859-e860. doi: 10.1016/S2214-109X(17)30269-3. No abstract available.

29.

Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.

Itchins M, Chia PL, Hayes SA, Howell VM, Gill AJ, Cooper WA, John T, Mitchell P, Millward M, Clarke SJ, Solomon B, Pavlakis N.

Asia Pac J Clin Oncol. 2017 Aug;13 Suppl 3:3-13. doi: 10.1111/ajco.12754. Review.

PMID:
28795492
30.

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB.

Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161.

PMID:
28777143
31.

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB.

Adv Anat Pathol. 2017 Sep;24(5):235-251. doi: 10.1097/PAP.0000000000000162.

PMID:
28777142
32.

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer.

John T, Bowden JJ, Clarke S, Fox SB, Garrett K, Horwood K, Karapetis CS.

Asia Pac J Clin Oncol. 2017 Aug;13(4):296-303. doi: 10.1111/ajco.12699. Epub 2017 Jul 12. Review.

PMID:
28699260
33.

Setting up recovery clinics and promoting service user involvement.

John T.

Br J Nurs. 2017 Jun 22;26(12):671-676. doi: 10.12968/bjon.2017.26.12.671.

PMID:
28640718
34.

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR Jr, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA; CheckMate 026 Investigators.

N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493.

35.

Parent Support of Preschool Peer Relationships in Younger Siblings of Children with Autism Spectrum Disorder.

Estes A, Munson J, John TS, Dager SR, Rodda A, Botteron K, Hazlett H, Schultz RT, Zwaigenbaum L, Piven J, Guralnick MJ; IBIS network.

J Autism Dev Disord. 2018 Apr;48(4):1122-1132. doi: 10.1007/s10803-017-3202-5.

PMID:
28634707
36.

Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.

Tamjid B, Phan P, John T, Mitchell P, Gan H.

Head Neck. 2017 Aug;39(8):1544-1549. doi: 10.1002/hed.24751. Epub 2017 Jun 7.

PMID:
28593651
37.

The Rights of Persons with Disabilities Act, 2016: Does it address the needs of the persons with mental illness and their families.

Narayan CL, John T.

Indian J Psychiatry. 2017 Jan-Mar;59(1):17-20. doi: 10.4103/psychiatry.IndianJPsychiatry_75_17. No abstract available.

38.

Vaccine delivery to disease control: a paradigm shift in health policy.

John TJ, Jain Y, Nadimpally S, Jesani A.

Indian J Med Ethics. 2017 Apr-Jun;2(2):112-115.

PMID:
28512077
39.

Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial.

Becher C, Laute V, Fickert S, Zinser W, Niemeyer P, John T, Diehl P, Kolombe T, Siebold R, Fay J.

J Orthop Surg Res. 2017 May 12;12(1):71. doi: 10.1186/s13018-017-0570-7.

41.

Surgical techniques and adjuvants for the management of primary and recurrent pterygia.

Hovanesian JA, Starr CE, Vroman DT, Mah FS, Gomes JAP, Farid M, Shamie N, Davidson RS, John T, Holland EJ, Kim T; ASCRS Cornea Clinical Committee.

J Cataract Refract Surg. 2017 Mar;43(3):405-419. doi: 10.1016/j.jcrs.2017.03.002. Review.

PMID:
28410726
42.

Is Mesothelioma in China Rare or Misdiagnosed?

John T, Russell PA, Thapa B.

J Thorac Oncol. 2017 Apr;12(4):607-609. doi: 10.1016/j.jtho.2017.02.004. No abstract available.

43.

Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis.

Al-Madol MA, Shaqura M, John T, Likar R, Ebied RS, Schäfer M, Mousa SA.

Mediators Inflamm. 2017;2017:9243736. doi: 10.1155/2017/9243736. Epub 2017 Feb 20.

44.

Standard of care in immunotherapy trials: Challenges and considerations.

Rivalland G, Scott AM, John T.

Hum Vaccin Immunother. 2017 Sep 2;13(9):2164-2178. doi: 10.1080/21645515.2016.1277845. Epub 2017 Mar 1.

45.

The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.

Thapa B, Salcedo A, Lin X, Walkiewicz M, Murone C, Ameratunga M, Asadi K, Deb S, Barnett SA, Knight S, Mitchell P, Watkins DN, Boutros PC, John T.

J Thorac Oncol. 2017 May;12(5):850-859. doi: 10.1016/j.jtho.2017.02.013. Epub 2017 Feb 28.

PMID:
28257959
46.

A Model for the Transient Subdiffusive Behavior of Particles in Mucus.

Ernst M, John T, Guenther M, Wagner C, Schaefer UF, Lehr CM.

Biophys J. 2017 Jan 10;112(1):172-179. doi: 10.1016/j.bpj.2016.11.900.

47.

Reply.

John T, Sheha H, Cheng AM.

Cornea. 2017 Feb;36(2):e4. doi: 10.1097/ICO.0000000000001080. No abstract available.

PMID:
28060080
48.

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators.

N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6.

49.

Lung cancer in 2016: immunotherapy comes of age.

Mitchell PL, John T.

Lancet Respir Med. 2016 Dec;4(12):947-949. doi: 10.1016/S2213-2600(16)30379-4. Epub 2016 Nov 22. No abstract available.

PMID:
27890503
50.

Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood.

John T, Lomeli N, Bota DA.

Behav Brain Res. 2017 Feb 15;319:200-206. doi: 10.1016/j.bbr.2016.11.013. Epub 2016 Nov 13.

Supplemental Content

Loading ...
Support Center